1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE 2 Ach ChE PAM ChE
|
|
- みさえ おおはし
- 5 years ago
- Views:
Transcription
1 1 - d- etc etc d-tc ChE > < < < > > > or d- < dtc Na + Na + I II ChE ChE ChE ( ) T Ca++ 1 Na + K + Na + Ach Ach Ach BTX Mg 2+ Ach CAT TTX Ach
2 1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE 2 Ach ChE PAM ChE
3 2 O O O O O O O O O O O O B BH + Na + ( )K + N N N Na + ph 1 2 etc pka=8.9 etc PABA 3 pka monoethyl glycinexylidine N- 4-hydroxy-2,6- dimethylaniline!! 1 pka=7 9 ph 3 PABA PABA pka ) 2 NE PABA Adr β 2
4 p56 fig.7-7 etc
5 3 N N ( ) ( ) M N N fast EPSP 1 2 C6 N N Ach (CH 3 ) 3 N-(CH 2 )n-n(ch 3 ) N M But p65 fig.7-14 Na + IPSP 3 slow EPSP 4 1 fast EPSP Ach Ach N N 1msec 35msec Na + n n= n n=α 4 slow EPSP 2 Ach α 2 100msec etc 3 IPSP
6 4 p ACh CCh BCh ChE ++ + ± ± & ACh > > > < <
7 5 α 1 Epi>NE Iso β 2 α 2 Epi>NE Iso? Ach β 1 Iso>Epi NE 1 β 2 Iso>Epi NE / ( etc) β 3 p52 fig.7-4 & Ach N N NE Epi NE 1 up up up
8 5.1 p NE etc COMT α 1 α 2 β 2 α β NE α 1 α 2 β 1 β 2 α 1 α 2 β 1 (β 2 ) β D β 1 β 1 α 1 β 2 α 1 β 2 2 β 1 β 1 β 2 2
9 5.2 Ch 5-HT D α 1 (sub: ) α 2 (NE ) α 1 α 2 β 1 β 2 β 1 β 2 (sub:β 2 ) α α 2 NE H 1 Ach Mg-ATP MAO / NE NE NE NE
10 6 p / etc 2 3 / 6.1 p79 fig8-3
11 6.2 MAC ED 50 50% 1 MAC / / B/G ? MAC > ?? Y Y Y Y Y Y ? ? / Glu-gen etc - ± / / / Epi Ca
12 : < ( ) = < 80% MAC with GOF with GOE with / / / 6.3 / + 70 / ( ) / etc < α Epi 1 + etc 2 ;
13 (10 15 ) GABA A GABA Cl Ca 2+ Cl Na + CO 2 CYP etc etc
14 3 6.4 GABA A ( ) GABA A ( ) α 2 GABA : GABA α 2 & α 2 (α 2 α 2 ) 4- K + ( ) 3
15 7 µ κ + = 7.1 µ = 1 / / / / Ru/ / / CTZ ( / ) (µ κ ) µ 1 µ / κ Ach σ δ / 4 2 Ach CO
16 7.2 ( 80 ) & 7.3 µ κ ( ) ( etc ) 7.4 n=narcotic µ κ δ n n β n + +
17 8 1 etc etc GABA B Ca 2+ K + 1 etc
18 9 etc D 2 1 GABA ( d) ( d) / ( d) ( ) D 2 GABA A GABA ( ) α + - D ( & ) ( &.+ ) / d=derivative etc & & 1/ D<ACh
19 10 / m m m camp PDE Ca 2+ Ca 2+ His & / NE/Epi/5-HT
20 10.2 p95 fig8-7 GABA A GABA GABA ( Cl Cl ) / 1 OK etc Clostridium tetani Renshaw Renshaw 1 :
21 & / (?) β 2 -Adr β 1 NG C PGF 2α
22 / etc d- His-N- etc H 1 H 2 / 3 / / H 1 M( ) H 2 ( r ) ( r ) ( r ) Na
23 HT (90%) / ( ) MAO 1 NO 5-HT 1 &5-HT 2 (for ) 5-HT LSD (for / ) 5-HT 1 5-HT 2
24 12.3 RAA Na Cl II / / Na + PG / / ADH p ACE AT 1
25 ph Hageman XII 2 PGE 2 ( p106) 2 B 2 B 1 des-arg des-arg B 3 etc
26 12.5 ( p107 PGs PGE 2 PGI 2 TXA 2 PGF 2 α LTB 4 LTC/D/E 4 WBC/ PGI 2 TXA 2 PGI 2 TXA cf.
27 13 ( p115) 13.1 NSAIDs COX( ) COX PGG 2 PGH 2 PG TX 1 PGE PGE ( ) / / etc PG & PGI2( ) TXA 2 ( ) DNA COX TXA 2 PGI COX-1 PGE 2 PGI 2 VitK CTZ NSAID COX PG / ( Na) COX PGE2 PGE2 LT LT PGF 2 α/pge 2 PGs / GABA ( / / / ) 1 PGE PGE
28 / + ( ) COX ( ) COX etc 13.2 etc 1. A2 2. COX-2 PG/TX WBC / φ
29 16 K Vit.K Fib DIC Vit.K Vit.K K etc II IX X ADP Na 2 EDTA Ca 2+ IV iv,im po i.m. p.o. p.o. i.m/v. Vit.B 12 1 Vit.B 12 Vit.B 12 RBC 1 Vit.B 12 RBC
30 t-pa
62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC -
1 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] g/dl A 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - [ ] Point ~ 62 [ ] [ ] [ ] [ ] [ ] [ ] / /
More information_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
More information
研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
More information国試過去問集.PDF
I 89 16 3 130 ab c AMPcAMP a 1 --- b c --- 2 --- --- 3 --- --- 4 --- --- 5 --- --- camp camp Ca 2+ β1 camp A camp camp A β1 p.156 β p.146 b. p.157 p135 (ANP) p157 c PDE-III p.157 p.157, 183 PDE C Ca PDE-III
More information第86回日本感染症学会総会学術集会後抄録(I)
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
More information1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b)
2010.1.13 1) 4) 2 18 1) 1 2 3 4 2) 1 2 85 3 3) 1 metabolizer 2 metabolizer 3 metabolizer 4 metabolizer 4) CYP 1 2 metabolizer 3 metabolizer 4 5 6 4 7 2 5 (PPI) 1 2 PPI 2 3 2 3 3 3 3 PPI 3 1 ph 4 5 1) 5)
More information=PAS.. =.. =.... 1% 01% ] = = = = 4 (A/A 2 / /B ) 1 8 2n / n n 64 n 64 n ] ] 4
1 1 1 1.1 1.1.1 3 : 0: + : +0 : : } 40 40 40 = 3 35 35 (38 )? +0+7 30 35-0+0 38 38 +30 5 30 30 +20 16 16 1. [ ] 2. 3. 4. + = etc 1.1.2 Ru 1 2 1.2 1.2.1 =PAS.. =.. =.... 1% 01% ] 1.2.2 = = = = 4 (A/A 2
More information1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
More informationnsg02-13/ky045059301600033210
φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W
More information近畿中国四国農業研究センター研究報告 第7号
230 C B A D E 50m 558 0 1km (mg L 1 ) T N NO 2 3 N NH 4 N 2.0 0 (a) 2001 1.5 6 20 21 5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 14:00 17:00 (b) 2001 7 3 4 20:00 23:00 2:00 (h) 5:00 8:00 11:00 10 0 5 10 15
More information122
121 122 123 1 124 2 3 125 4 5 126 7 127 8 9 128 17301 10 1. 2. 3. 4. 5. 11 129 12 13 130 211822 14 15 131 16 17 132 5 19 133 20 21 134 22 23 135 24 25 136 26 137 1. 2. 3. 4. 5. 5 28 1. 5 2. 3. 3 29 138
More informationI II III IV V
I II III IV V N/m 2 640 980 50 200 290 440 2m 50 4m 100 100 150 200 290 390 590 150 340 4m 6m 8m 100 170 250 µ = E FRVβ β N/mm 2 N/mm 2 1.1 F c t.1 3 1 1.1 1.1 2 2 2 2 F F b F s F c F t F b F s 3 3 3
More information10 10 10 1 2 3 4 2 2 4 5 6 7 8 1 9 1011 S 10 1 2 3 4 5 10 10 10 1 2 3 4 5 6 2 7 8 9 10 10 2 14 3 2 4 10 11 12 13 14 1521 15 16 15 16 ( ) 17 18 19 20 21 1 10 4 1 2 5 3 2 II 2 3 ( ) 5 21 5 22 2 3 23
More information九州支部卒後研修会症例
血液検査研修会 ( 第 25 回 ) 検査の異常から探る! 造血器腫瘍へのアプローチ 症例提示 症例 1~8 - 症例発表者 - 症例 1 藤崎恵熊本医療センター 症例 2 荒木敏造浜の町病院 症例 3 古城剛鹿児島大学病院 症例 4 佐々木高太郎都城健康サービスセンター 症例 5 矢田佳愛 大分県立病院 症例 6 下田博臣 健康保険諫早総合病院 症例 7 堤陽子 佐賀県医療センター好生館 症例 8
More informationA(6, 13) B(1, 1) 65 y C 2 A(2, 1) B( 3, 2) C 66 x + 2y 1 = 0 2 A(1, 1) B(3, 0) P 67 3 A(3, 3) B(1, 2) C(4, 0) (1) ABC G (2) 3 A B C P 6
1 1 1.1 64 A6, 1) B1, 1) 65 C A, 1) B, ) C 66 + 1 = 0 A1, 1) B, 0) P 67 A, ) B1, ) C4, 0) 1) ABC G ) A B C P 64 A 1, 1) B, ) AB AB = 1) + 1) A 1, 1) 1 B, ) 1 65 66 65 C0, k) 66 1 p, p) 1 1 A B AB A 67
More information09_organal2
4. (1) (a) I = 1/2 (I = 1/2) I 0 p ( ), n () I = 0 (p + n) I = (1/2, 3/2, 5/2 ) p ( ), n () I = (1, 2, 3 ) (b) (m) (I = 1/2) m = +1/2, 1/2 (I = 1/2) m = +1/2, 1/2 I m = +I, +(I 1), +(I 2) (I 1), I ( )
More information高脂血症の検査
35 30 Buffy coatbuffy coat EDTA Na Na Ca RBC Hb Ht WBC Plt ESR TP Alb CRP GOTGPTLDH BUN Cre UA HbA1C TC TG NaKClCaPFe B12 36 RBC 410530 /μl 380480 /μl Hb 13.517.6g/dL 11.315.2g/dL Ht 3648% 3443% MCV MCH
More information漸化式のすべてのパターンを解説しましたー高校数学の達人・河見賢司のサイト
https://www.hmg-gen.com/tuusin.html https://www.hmg-gen.com/tuusin1.html 1 2 OK 3 4 {a n } (1) a 1 = 1, a n+1 a n = 2 (2) a 1 = 3, a n+1 a n = 2n a n a n+1 a n = ( ) a n+1 a n = ( ) a n+1 a n {a n } 1,
More informationuntitled
PGF 17 6 1 11 1 12 1 2 21 2 22 2 23 3 1 3 1 3 2 3 3 3 4 3 5 4 6 4 2 4 1 4 2 4 3 4 4 4 5 5 3 5 1 5 2 5 5 5 5 4 5 1 5 2 5 3 6 5 6 1 6 2 6 6 6 24 7 1 7 1 7 2 7 3 7 4 8 2 8 1 8 2 8 3 9 4 9 5 9 6 9 3 9 1 9
More informationα β *2 α α β β α = α 1 β = 1 β 2.2 α 0 β *3 2.3 * *2 *3 *4 (µ A ) (µ P ) (µ A > µ P ) 10 (µ A = µ P + 10) 15 (µ A = µ P +
Armitage 1 1.1 2 t *1 α β 1.2 µ x µ 2 2 2 α β 2.1 1 α β α ( ) β *1 t t 1 α β *2 α α β β α = α 1 β = 1 β 2.2 α 0 β 1 0 0 1 1 5 2.5 *3 2.3 *4 3 3.1 1 1 1 *2 *3 *4 (µ A ) (µ P ) (µ A > µ P ) 10 (µ A = µ P
More information3 5 18 3 5000 1 2 7 8 120 1 9 1954 29 18 12 30 700 4km 1.5 100 50 6 13 5 99 93 34 17 2 2002 04 14 16 6000 12 57 60 1986 55 3 3 3 500 350 4 5 250 18 19 1590 1591 250 100 500 20 800 20 55 3 3 3 18 19 1590
More information物理化学I-第12回(13).ppt
I- 12-1 11 11.1 2Mg(s) + O 2 (g) 2MgO(s) [Mg 2+ O 2 ] Zn(s) + Cu 2+ (aq) Zn 2+ (aq) + Cu(s) - 2Mg(s) 2Mg 2+ (s) + 4e +) O 2 (g) + 4e 2O 2 (s) 2Mg(s) + O 2 (g) 2MgO(s) Zn(s) Zn 2+ (aq) + 2e +) Cu 2+ (aq)
More information名古屋工業大の数学 2000 年 ~2015 年 大学入試数学動画解説サイト
名古屋工業大の数学 年 ~5 年 大学入試数学動画解説サイト http://mathroom.jugem.jp/ 68 i 4 3 III III 3 5 3 ii 5 6 45 99 5 4 3. () r \= S n = r + r + 3r 3 + + nr n () x > f n (x) = e x + e x + 3e 3x + + ne nx f(x) = lim f n(x) lim
More information13,825,228 3,707,995 26.8 4.9 25 3 8 9 1 50,000 0.29 1.59 70,000 0.29 1.74 12,500 0.39 1.69 12,500 0.55 10,000 20,000 0.13 1.58 30,000 0.00 1.26 5,000 0.13 1.58 25,000 40,000 0.13 1.58 50,000 0.00 1.26
More information( ) Note (e ) (µ ) (τ ) ( (ν e,e ) e- (ν µ, µ ) µ- (ν τ,τ ) τ- ) ( ) ( ) (SU(2) ) (W +,Z 0,W ) * 1) 3 * 2) [ ] [ ] [ ] ν e ν µ ν τ e
( ) Note 3 19 12 13 8 8.1 (e ) (µ ) (τ ) ( (ν e,e ) e- (ν µ, µ ) µ- (ν τ,τ ) τ- ) ( ) ( ) (SU(2) ) (W +,Z 0,W ) * 1) 3 * 2) [ ] [ ] [ ] ν e ν µ ν τ e µ τ, e R, µ R, τ R (1a) L ( ) ) * 3) W Z 1/2 ( - )
More information総合薬学講座 生物統計の基礎
2013 10 22 ( ) 2013 10 22 1 / 40 p.682 1. 2. 3 2 t Mann Whitney U ). 4 χ 2. 5. 6 Dunnett Tukey. 7. 8 Kaplan Meier.. U. ( ) 2013 10 22 2 / 40 1 93 ( 20 ) 230. a t b c χ 2 d 1.0 +1.0 e, b ( ) e ( ) ( ) 2013
More information006 11 8 0 3 1 5 1.1..................... 5 1......................... 6 1.3.................... 6 1.4.................. 8 1.5................... 8 1.6................... 10 1.6.1......................
More information医系の統計入門第 2 版 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます. このサンプルページの内容は, 第 2 版 1 刷発行時のものです.
医系の統計入門第 2 版 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます. http://www.morikita.co.jp/books/mid/009192 このサンプルページの内容は, 第 2 版 1 刷発行時のものです. i 2 t 1. 2. 3 2 3. 6 4. 7 5. n 2 ν 6. 2 7. 2003 ii 2 2013 10 iii 1987
More information1 (1) () (3) I 0 3 I I d θ = L () dt θ L L θ I d θ = L = κθ (3) dt κ T I T = π κ (4) T I κ κ κ L l a θ L r δr δl L θ ϕ ϕ = rθ (5) l
1 1 ϕ ϕ ϕ S F F = ϕ (1) S 1: F 1 1 (1) () (3) I 0 3 I I d θ = L () dt θ L L θ I d θ = L = κθ (3) dt κ T I T = π κ (4) T I κ κ κ L l a θ L r δr δl L θ ϕ ϕ = rθ (5) l : l r δr θ πrδr δf (1) (5) δf = ϕ πrδr
More informationパソコン機能ガイド
PART12 ii iii iv v 1 2 3 4 5 vi vii viii ix P A R T 1 x P A R T 2 xi P A R T 3 xii xiii P A R T 1 2 3 1 4 5 1 6 1 1 2 7 1 2 8 1 9 10 1 11 12 1 13 1 2 3 4 14 1 15 1 2 3 16 4 1 1 2 3 17 18 1 19 20 1 1
More informationパソコン機能ガイド
PART2 iii ii iv v 1 2 3 4 5 vi vii viii ix P A R T 1 x P A R T 2 xi P A R T 3 xii xiii P A R T 1 2 1 3 4 1 5 6 1 2 1 1 2 7 8 9 1 10 1 11 12 1 13 1 2 3 14 4 1 1 2 3 15 16 1 17 1 18 1 1 2 19 20 1 21 1 22
More information2 129-B*-006P 129-B*-007P C*-004P 129-D*-001P ADH B*-006P B*-007P C*-004P D*-001P Na
2.7.4 2.7.4.1 2.7.4.1.1 11 ADH 1 ADH 1 4 7 129-A*-003 129-B*-001 129-E*-001P 129-G*-001 129-H*-002 129-H*-004 129-H*-005 132 242 4 129-B*-004 129-C*-005P 129-H*-003 129-H*-006 44 ADH ADH 129-C*-001P 16
More informationI
I II III IV V VI VII VIII IX X XI XII XIII XIV 1. 2 3 4 5 2. 6 7 8 3. 1 2 3 9 4 5 10 6 11 4. 1 2 3 1 2 12 1 2 3 1 2 3 13 14 1 2 1 15 16 1. 20 1 21 1 22 23 1 2 3 4 24 1 2 ok 25 1 2 26 1 2 3 27 2. 28
More information36 th IChO : - 3 ( ) , G O O D L U C K final 1
36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic
More information1... 1 2... 1 1... 1 2... 2 3... 2 4... 4 5... 4 6... 4 7... 22 8... 22 3... 22 1... 22 2... 23 3... 23 4... 24 5... 24 6... 25 7... 31 8... 32 9... 3
3 2620149 3 6 3 2 198812 21/ 198812 21 1 3 4 5 JISJIS X 0208 : 1997 JIS 4 JIS X 0213:2004 http://www.pref.hiroshima.lg.jp/site/monjokan/ 1... 1 2... 1 1... 1 2... 2 3... 2 4... 4 5... 4 6... 4 7... 22
More information24 201170068 1 4 2 6 2.1....................... 6 2.1.1................... 6 2.1.2................... 7 2.1.3................... 8 2.2..................... 8 2.3................. 9 2.3.1........... 12
More information24 I ( ) 1. R 3 (i) C : x 2 + y 2 1 = 0 (ii) C : y = ± 1 x 2 ( 1 x 1) (iii) C : x = cos t, y = sin t (0 t 2π) 1.1. γ : [a, b] R n ; t γ(t) = (x
24 I 1.1.. ( ) 1. R 3 (i) C : x 2 + y 2 1 = 0 (ii) C : y = ± 1 x 2 ( 1 x 1) (iii) C : x = cos t, y = sin t (0 t 2π) 1.1. γ : [a, b] R n ; t γ(t) = (x 1 (t), x 2 (t),, x n (t)) ( ) ( ), γ : (i) x 1 (t),
More information活用ガイド (ソフトウェア編)
ii iii iv NEC Corporation 1998 v vi PA RT 1 vii PA RT 2 viii PA RT 3 PA RT 4 ix P A R T 1 2 3 1 4 5 1 1 2 1 2 3 4 6 1 2 3 4 5 7 1 6 7 8 1 9 1 10 1 2 3 4 5 6 7 8 9 10 11 11 1 12 12 1 13 1 1 14 2 3 4 5 1
More information2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO
1 [1]. Zn + 2 H + Zn 2+,. K Ca Na Mg Al Zn Fe Ni Sn Pb H Cu Hg Ag Pt Au H (H + ),,. [2] ( ) ( ) CO 2, S, SO 2, NH 3 () + () () + () FeS Fe S ( ) + ( ) ( ) + ( ) 2 NH 4 Cl + Ca(OH) 2 Ca O + 2 NH 3,.,,.,,.,.
More information( ) ,
II 2007 4 0. 0 1 0 2 ( ) 0 3 1 2 3 4, - 5 6 7 1 1 1 1 1) 2) 3) 4) ( ) () H 2.79 10 10 He 2.72 10 9 C 1.01 10 7 N 3.13 10 6 O 2.38 10 7 Ne 3.44 10 6 Mg 1.076 10 6 Si 1 10 6 S 5.15 10 5 Ar 1.01 10 5 Fe 9.00
More information1.500 m X Y m m m m m m m m m m m m N/ N/ ( ) qa N/ N/ 2 2
1.500 m X Y 0.200 m 0.200 m 0.200 m 0.200 m 0.200 m 0.000 m 1.200 m m 0.150 m 0.150 m m m 2 24.5 N/ 3 18.0 N/ 3 30.0 0.60 ( ) qa 50.79 N/ 2 0.0 N/ 2 20.000 20.000 15.000 15.000 X(m) Y(m) (kn/m 2 ) 10.000
More informationリファレンス
STEP1 STEP 2 STEP 3 ii iii iv v NEC Corporation 1998 vi C O N T E N T S P A R T 1 viii ix C O N T E N T S P A R T 2 x P A R T 3 xi C O N T E N T S P A R T 4 xii P A R T 5 xiii C O N T E N T S P A R T
More information(iii) 0 V, x V, x + 0 = x. 0. (iv) x V, y V, x + y = 0., y x, y = x. (v) 1x = x. (vii) (α + β)x = αx + βx. (viii) (αβ)x = α(βx)., V, C.,,., (1)
1. 1.1...,. 1.1.1 V, V x, y, x y x + y x + y V,, V x α, αx αx V,, (i) (viii) : x, y, z V, α, β C, (i) x + y = y + x. (ii) (x + y) + z = x + (y + z). 1 (iii) 0 V, x V, x + 0 = x. 0. (iv) x V, y V, x + y
More informationH22応用物理化学演習1_濃度.ppt
1 2 4/12 4/19 4/27 5/10 5/17 5/24 5/31 (20 ) (20 ) (10 ) (50 ) 3 (mole fraction) X = (mol) (mol) i n 1, n 2,, n x N i X i = n i = n i n 1 + n 2 + + n x N 4 (molarity, M) 1 dm 3 ( L) (mol) (mol/l) = 1 L
More information1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e
No. 1 1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e I X e Cs Ba F Ra Hf Ta W Re Os I Rf Db Sg Bh
More informationuntitled
Metabolic syndrome,,,, 81 81 , 17 17 2 Lung Ca non small cell carcinoma / / food( food( ) drug( drug( ) 100mg 750mg WBC 5510/ l RBC 483 / l Hb 10.3g/dl, Ht 42.0% Plt 19.0 / l TP 8.1g/dl Alb 4.6g/dl Glb
More information2004 2006 1997 10 1999 2000 2005 2006 2007 5-8a 100 1979 1980 1980 1980 2 4 1981 1981 1982 1982 1982 1983 1984 1 1985 1985 1988 1990 1991 1993 1993 19
[ ] 5-7 1998 1998 1999 1999 2001 2002 2002 2002 2003 2003 2005 Communication 2005 2006 2006 2007 SE 2007 2001 2005 2007 PR PR 1999 2000 PR 2003 56 2004 2006 1997 10 1999 2000 2005 2006 2007 5-8a 100 1979
More informationSuper perfect numbers and Mersenne perefect numbers /2/22 1 m, , 31 8 P = , P =
Super perfect numbers and Mersenne perefect numbers 3 2019/2/22 1 m, 2 2 5 3 5 4 18 5 20 6 25 7, 31 8 P = 5 35 9, 38 10 P = 5 39 1 1 m, 1: m = 28 m = 28 m = 10 height48 2 4 3 A 40 2 3 5 A 2002 2 7 11 13
More information金融商品取引業の業規制
2009 3 11 2 8 Cf. 4 60 11 1 2 3 4 5 4 56 1 318 44 2 7 147 2005 3 395 5 2006 4 2 34 35 2003 5 1 1 8 3 2 8 1 8 3 15 16 Cf. 1-1 42 1-1 40 2 20 2 21 2 16 14 2 15 8 3 1 2 15 6 10 1-1 45 6 44 3 1 8 3 1 4 16
More information™…
i 1 1 1 2 3 5 5 6 7 9 10 11 13 13 14 15 15 16 17 18 20 20 20 21 22 ii CONTENTS 23 24 26 27 2 31 31 32 32 33 34 37 37 38 39 39 40 42 42 43 44 45 48 50 51 51 iii 54 57 58 60 60 62 64 64 67 69 70 iv 70 71
More information3章 問題・略解
S S W R S O( l) O( ) c Jg g J Jg S R J 7. K.9 JK S W S R S JK S S R J 7. K.9JK 4 (a) -Tice 7.K T ice T N 77 K S R.9 JK 4. JK T T ice N.6JK S W S R S JK S S.6JK R (b) S R JK S.6 JK T T ice N 6 O( c) O(
More informationMicrosoft Word - .....J.^...O.|Word.i10...j.doc
P 1. 2. R H C H, etc. R' n R' R C R'' R R H R R' R C C R R C R' R C R' R C C R 1-1 1-2 3. 1-3 1-4 4. 5. 1-5 5. 1-6 6. 10 1-7 7. 1-8 8. 2-1 2-2 2-3 9. 2-4 2-5 2-6 2-7 10. 2-8 10. 2-9 10. 2-10 10. 11. C
More information4 1 Ampère 4 2 Ampere 31
4. 2 2 Coulomb 2 2 2 ( ) electricity 2 30 4 1 Ampère 4 2 Ampere 31 NS 2 Fleming 4 3 B I r 4 1 0 1.257 10-2 Gm/A µ 0I B = 2πr 4 1 32 4 4 A A A A 4 4 10 9 1 2 12 13 14 4 1 16 4 1 CH 2 =CH 2 28.0313 28 2
More informationarxiv: v1(astro-ph.co)
arxiv:1311.0281v1(astro-ph.co) R µν 1 2 Rg µν + Λg µν = 8πG c 4 T µν Λ f(r) R f(r) Galileon φ(t) Massive Gravity etc... Action S = d 4 x g (L GG + L m ) L GG = K(φ,X) G 3 (φ,x)φ + G 4 (φ,x)r + G 4X (φ)
More information活用ガイド (ハードウェア編)
(Windows 98) 808-877675-122-A ii iii iv NEC Corporation 1999 v vi PART 1 vii viii PART 2 PART 3 ix x xi xii P A R T 1 2 1 3 4 1 5 6 1 7 8 1 9 10 11 1 12 1 1 2 3 13 1 2 3 14 4 5 1 15 1 1 16 1 17 18 1 19
More information(e ) (µ ) (τ ) ( (ν e,e ) e- (ν µ,µ ) µ- (ν τ,τ ) τ- ) ( ) ( ) ( ) (SU(2) ) (W +,Z 0,W ) * 1) [ ] [ ] [ ] ν e ν µ ν τ e µ τ, e R,µ R,τ R (2.1a
1 2 2.1 (e ) (µ ) (τ ) ( (ν e,e ) e- (ν µ,µ ) µ- (ν τ,τ ) τ- ) ( ) ( ) ( ) (SU(2) ) (W +,Z 0,W ) * 1) [ ] [ ] [ ] ν e ν µ ν τ e µ τ, e R,µ R,τ R (2.1a) L ( ) ) * 2) W Z 1/2 ( - ) d u + e + ν e 1 1 0 0
More information日本呼吸器学会雑誌第44巻第1号
β β l β β Table1 Laboratorydataonadmission Hematology WBC 9,910/μl neut 72.4% lym 20.2% eos 0.9% mon 6.1% baso 0.4% RBC 491 10 4 /μl Hb 16.8g/dl Ht 48.3% PLT 29.8 10 4 /μl ESR 3mm/hr Biochemistry TP Alb
More informationml DNA DNA
ml DNA DNA ml PH HO DNADNA DNA LED LED CD CD ch 概 概 mll IC LED OK CD CDDVD CD LED LED LED The LED PVA Part LED LED PPT V LED AI LED V AlCu Fe Al Al PVA ml 概 概 CD CD OHP etc cm PET cm PET cm PET LED LED
More information14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
More information44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
More informationi ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
More information10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1
4 16 1 10:0010 : 24 1F Annex 1! 2 15:0015 : 24 1F Annex 1!! 10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 ! 2 10:0010 : 28 1F Annex 1 3 15:0015 : 28 1F Annex 1 4 10:3010 : 58 1F Annex 1 1 15:3015
More information03J_sources.key
Radiation Detection & Measurement (1) (2) (3) (4)1 MeV ( ) 10 9 m 10 7 m 10 10 m < 10 18 m X 10 15 m 10 15 m ......... (isotope)...... (isotone)......... (isobar) 1 1 1 0 1 2 1 2 3 99.985% 0.015% ~0% E
More informationSC-85X2取説
I II III IV V VI .................. VII VIII IX X 1-1 1-2 1-3 1-4 ( ) 1-5 1-6 2-1 2-2 3-1 3-2 3-3 8 3-4 3-5 3-6 3-7 ) ) - - 3-8 3-9 4-1 4-2 4-3 4-4 4-5 4-6 5-1 5-2 5-3 5-4 5-5 5-6 5-7 5-8 5-9 5-10 5-11
More information3/4/8:9 { } { } β β β α β α β β
α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3
More information387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )
386 B B () () ( ) ( ) ( ) 387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 388 ( ) ( ) ( ) 389 ( ) 2 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 390 ( ) ( ) ( ) () () ( ) Hot flush 391 ( ) ( ) ( ) 392 ( ( )
More information(iii) x, x N(µ, ) z = x µ () N(0, ) () 0 (y,, y 0 ) (σ = 6) *3 0 y y 2 y 3 y 4 y 5 y 6 y 7 y 8 y 9 y ( ) *4 H 0 : µ
t 2 Armitage t t t χ 2 F χ 2 F 2 µ, N(µ, ) f(x µ, ) = ( ) exp (x µ)2 2πσ 2 2 0, N(0, ) (00 α) z(α) t * 2. t (i)x N(µ, ) x µ σ N(0, ) 2 (ii)x,, x N(µ, ) x = x + +x ( N µ, σ2 ) (iii) (i),(ii) x,, x N(µ,
More information